Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1

Conditions

Melanoma 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 613pembrolizumab 568Magnetic Resonance Spectroscopy 538Carboplatin 429Cyclophosphamide 381Cisplatin 374Biopsy 355Paclitaxel 312Nivolumab 307Gemcitabine 302Radiotherapy 260Bevacizumab 237Dexamethasone 213fludarabine 207Docetaxel 189durvalumab 181atezolizumab 175Oxaliplatin 171Rituximab 167Fluorouracil 167venetoclax 166Pemetrexed 164Doxorubicin 161Capecitabine 158Radiation 157Radiosurgery 147Etoposide 138Leucovorin 134Ipilimumab 134Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ketones × 90 days × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡